1.上海中医药大学(上海 201203)
2.上海市光华中西医结合医院(上海 200052)
时一鸣,女,硕士研究生,主要从事类风湿关节炎的临床和实验研究工作
何东仪,主任医师,教授,博士研究生导师; E-mail:hedongyi1967@shutcm.edu.cn
扫 描 看 全 文
时一鸣,常岑,姜平,等.中药单体化合物调控NF⁃κB信号通路干预类风湿关节炎的研究进展[J].上海中医药杂志,2023,57(10):89-94.
SHI Yiming,CHANG Cen,JIANG Ping,et al.Research progress on monomeric compounds of traditional Chinese medicine regulating NF‑κB signaling pathway to intervene rheumatoid arthritis[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(10):89-94.
时一鸣,常岑,姜平,等.中药单体化合物调控NF⁃κB信号通路干预类风湿关节炎的研究进展[J].上海中医药杂志,2023,57(10):89-94. DOI: 10.16305/j.1007-1334.2023.2305011.
SHI Yiming,CHANG Cen,JIANG Ping,et al.Research progress on monomeric compounds of traditional Chinese medicine regulating NF‑κB signaling pathway to intervene rheumatoid arthritis[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(10):89-94. DOI: 10.16305/j.1007-1334.2023.2305011.
综述中药单体化合物调控核因子-κB (NF-κB)信号通路干预类风湿关节炎的研究进展。NF-κB存在于多种细胞内,参与类风湿关节炎的发生发展,中药单体化合物通过抑制NF-κB通路的激活,调节靶基因的转录,影响细胞增殖、存活及炎症因子表达等多种生物学行为,发挥抗炎、免疫调节、骨保护等治疗作用。
The research progress on the regulation of nuclear factor-κB (NF-κB) signaling pathway in rheumatoid arthritis by monomeric compounds of traditional Chinese medicine was reviewed. NF-κB is presented in a variety of cells and involved in the development of rheumatoid arthritis. By inhibiting the activation of NF-κB pathway, monomeric compounds of traditional Chinese medicine regulate the transcription of target genes and affect various biological behaviors such as cell proliferation, survival and expression of inflammatory factors, and play a therapeutic role in anti-inflammatory, immune regulation and bone protection.
类风湿关节炎中药单体化合物作用机制研究进展
rheumatoid arthritistraditional Chinese medicinemonomeric compoundsmechanism of actionresearch progress
FIRESTEIN G S. Evolving concepts of rheumatoid arthritis[J]. Nature, 2003, 423(6937): 356-361.
VAN DER HEIJDE D M. Joint erosions and patients with early rheumatoid arthritis[J]. Br J Rheumatol, 1995, 34 (Suppl 2): 74-78.
CUTOLO M, KITAS G D, VAN RIEL P L. Burden of disease in treated rheumatoid arthritis patients: going beyond the joint[J]. Semin Arthritis Rheum, 2014, 43(4): 479-488.
GUNASEKERA W M, KIRWAN J R. Rheumatoid arthritis: previously untreated early disease [J]. BMJ Clin Evid, 2016, 2016: 1124.
MITTAL N, MITTAL R, SHARMA A, et al. Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients[J]. Singapore Med J, 2012, 53(8): 532-536.
GUO X, JI J, ZHANG J, et al. Anti-inflammatory and osteoprotective effects of chikusetsusaponin Ⅳa on rheumatoid arthritis via the JAK/STAT signaling pathway[J]. Phytomedicine, 2021, 93: 153801.
LI P, HUANG Y, WANG J, et al. Platycodin D relieves rheumatoid arthritis by promoting apoptosis of mitochondria to inhibit activation of hedgehog pathway[J]. Autoimmunity, 2023, 56(1): 2205053.
YANG J, LIU J, LI J, et al. Celastrol inhibits rheumatoid arthritis by inducing autophagy via inhibition of the PI3K/AKT/mTOR signaling pathway[J]. Int Immunopharmacol, 2022, 112: 109241.
LI J, TANG R S, SHI Z, et al. Nuclear factor-κB in rheumatoid arthritis[J]. Int J Rheum Dis, 2020, 23(12): 1627-1635.
HOESEL B, SCHMID J A. The complexity of NF-κB signaling in inflammation and cancer [J]. Mol Cancer, 2013, 12: 86.
ZARRIN A A, BAO K, LUPARDUS P, et al. Kinase inhibition in autoimmunity and inflammation[J]. Nat Rev Drug Discov, 2021, 20(1): 39-63.
FAGAN-GARCIA K, BARRY M. A vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB[J]. J Virol, 2011, 85(2): 883-894.
MOYNAGH P N. The NF-kappaB pathway[J]. J Cell Sci, 2005, 118(Pt 20): 4589-4592.
VALLABHAPURAPU S, KARIN M. Regulation and function of NF-kappaB transcription factors in the immune system[J]. Annu Rev Immunol, 2009, 27: 693-733.
PFLUG K M, SITCHERAN R. Targeting NF-κB-inducing kinase (NIK) in immunity, inflammation, and cancer[J]. Int J Mol Sci, 2020, 21(22): 8470.
KARIN M. Nuclear factor-kappaB in cancer development and progression[J]. Nature, 2006, 441(7092): 431-436.
KUTUK O, BASAGA H. Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis[J]. Trends Mol Med, 2003, 9(12): 549-557.
ATREYA I, ATREYA R, NEURATH M F. NF-kappaB in inflammatory bowel disease[J]. J Intern Med, 2008, 263(6): 591-596.
ROMAN-BLAS J A, JIMENEZ S A. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis[J]. Osteoarthritis Cartilage, 2006, 14(9): 839-848.
STRUZIK J, SZULC-DĄBROWSKA L. Manipulation of non-canonical NF-κB signaling by non-oncogenic viruses[J]. Arch Immunol Ther Exp (Warsz), 2019, 67(1): 41-48.
WANG Y, GAO W. Effects of TNF-α on autophagy of rheumatoid arthritis fibroblast-like synoviocytes and regulation of the NF-κB signaling pathway[J]. Immunobiology, 2021, 226(2): 152059.
CLANCHY F I L, BORGHESE F, BYSTROM J, et al. TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis[J]. J Autoimmun, 2021, 118: 102597.
ANDREAKOS E, SACRE S, FOXWELL B M, et al. The toll-like receptor-nuclear factor kappaB pathway in rheumatoid arthritis[J]. Front Biosci, 2005, 10: 2478-2488.
ZHANG L L, XIAO H, ZHANG F, et al. BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis[J]. Acta Pharmacol Sin, 2021, 42(10): 1665-1675.
SCHETT G, GRAVALLESE E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment[J]. Nat Rev Rheumatol, 2012, 8(11): 656-664.
ILCHOVSKA D D, BARROW D M. An Overview of the NF‑κB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-κB ligand RANKL and related nutritional interventions [J]. Autoimmun Rev, 2021, 20(2): 102741.
管鑫,李若诗,段宝忠,等. 重楼属植物化学成分、药理作用研究进展及质量标志物预测分析[J]. 中草药,2019, 50(19): 4838-4852.
余思宜,钏定泽,刘俊红,等. 滇重楼中皂苷的精制及其抗炎功效验证[J]. 当代化工,2023, 52(2): 277-284,369.
WANG Q, ZHOU X, ZHAO Y, et al. Polyphyllin I ameliorates collagen-induced arthritis by suppressing the inflammation response in macrophages through the NF-κB pathway[J]. Front Immunol, 2018, 9: 2091.
翟芷淇,付悦,张馨月,等. 槲皮素脂质体抑制小鼠肺组织炎症作用的研究[J]. 药物评价研究,2023, 46(1): 50-55.
章秋霞,陈炯科,吴伶莉. 槲皮素通过上调miR-140-5p抑制呼吸道合胞病毒感染的支气管上皮细胞凋亡和炎症反应的实验研究 [J]. 免疫学杂志,2022, 38(10): 883-889.
周新欢,杨弋弋,任红娟,等. 基于JAK-STAT信号通路探讨槲皮素对宫颈癌细胞增殖、凋亡和转移的影响[J]. 新中医,2022, 54(21): 144-148.
王友庆,陈士芳,梅珏. 槲皮素通过抑制NF-κB减弱类风湿关节炎大鼠软骨细胞基质降解和细胞凋亡[J]. 免疫学杂志,2019, 35(6): 485-491.
都梦帆,胥冰,向汝,等. 苦参碱注射液对小鼠急性酒精性肝损伤的保护作用[J]. 中国现代医学杂志,2021, 31(24): 13-18.
贾绍华,孙萌遥,丁海鑫,等. 苦参碱对人乳腺癌MCF-7细胞自噬及细胞凋亡的影响 [J]. 中药材,2023, 46(3): 724-729.
杨筱,张艳荣,乔志远,等. 苦参碱对假丝酵母菌阴道炎大鼠的药效及其局部免疫功能的影响[J]. 中成药,2022, 44(3): 968-971.
NIU Y, DONG Q, LI R. Matrine regulates Th1/Th2 cytokine responses in rheumatoid arthritis by attenuating the NF-κB signaling[J]. Cell Biol Int, 2017, 41(6): 611-621.
赵鹏,李彬,何为涛,等. 三七皂甙对小鼠免疫功能影响的实验研究[J]. 中国热带医学,2004, 4(4): 522-524.
JIAO D, LIU Y, HOU T, et al. Notoginsenoside R1 (NG-R1) promoted lymphatic drainage function to ameliorating rheumatoid arthritis in TNF-Tg mice by suppressing NF-κB signaling pathway[J]. Front Pharmacol, 2021, 12: 730579.
TANG W, ZUO J P. Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8) [J]. Acta Pharmacol Sin, 2012, 33(9): 1112-1118.
刘佳,童萍,左建平,等. LLDT-8对类风湿关节炎滑膜细胞NF‑κB信号通路的影响[J]. 现代免疫学,2018, 38(4): 265-270.
何巧燕,王知平,王芳. 龙胆苦苷对D-氨基半乳糖联合脂多糖诱导的慢性肝损伤模型小鼠的保护作用 [J]. 山西中医药大学学报,2022, 23(3): 168-172.
李玉博. 龙胆苦苷调控TGF-β/Smads通路并减轻炎症与氧化应激反应改善大鼠腹膜纤维化[D]. 泸州:西南医科大学,2022.
宋帅,张鑫平,杨鋆. 龙胆苦苷对人结肠癌HCT116细胞增殖、凋亡的影响[J]. 临床和实验医学杂志,2022, 21(14): 1473-1477.
WANG M, LI H, WANG Y, et al. Anti-rheumatic properties of gentiopicroside are associated with suppression of ROS-NF-κB-NLRP3 axis in fibroblast-like synoviocytes and NF‑κB pathway in adjuvant-induced arthritis[J]. Front Pharmacol, 2020, 11: 515.
石翠格,李慧,王丽丽,等. 淫羊藿苷抗抑郁及对皮质酮致PC12细胞损伤的保护作用研究[J]. 中国药物应用与监测,2013, 10(5): 268-270.
白晓君,刘艳,郜珊珊,等. 淫羊藿苷抑制氧化应激诱导主动脉血管平滑肌细胞钙化的机制研究[J]. 中国中药杂志,2021, 46(17): 4497-4503.
吕雅鑫,陈龙,蒋义鑫,等. 淫羊藿苷抑制非小细胞肺癌生长的代谢组学研究[J]. 上海中医药杂志,2021, 55(6): 84-90.
WU Z M, XIANG Y R, ZHU X B, et al. Icariin represses the inflammatory responses and survival of rheumatoid arthritis fibroblast-like synoviocytes by regulating the TRIB1/TLR2/NF-κB pathway [J]. Int Immunopharmacol, 2022, 110: 108991.
王洪军,于淼,王云鹤,等. 黄芪总黄酮对柯萨奇B3病毒感染心肌细胞内质网应激及促凋亡信号因子作用 [J]. 临床心血管病杂志,2016, 32(1): 70-73.
张冬青. 黄芪总黄酮及其活性成分对肿瘤细胞的抑制作用与机理研究[D]. 北京:中国人民解放军军医进修学院,2010.
汪德清,丁保国,NEIL T G,等. 黄芪总黄酮对动脉粥样硬化早期形成的影响[J]. 中国药理学通报,2003, 10(6): 637-640.
唐静,许娟娟,袁秀芝. 不同浓度黄芪总黄酮对高糖诱导人脐静脉系内皮细胞损伤的保护作用[J]. 中西医结合研究,2020, 12(3): 160-164.
LIU X Y, XU L, WANG Y, et al. Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway[J]. Int Immunopharmacol, 2017, 44: 105-114.
张玮璨,范秀华,豆艳艳,等. 黄芩苷对沙眼衣原体生殖道感染小鼠免疫功能及炎症因子水平的影响[J]. 中华医院感染学杂志,2022, 32(18): 2725-2729.
黄伟琨,徐秋艳,周婷. 黄芩苷抑制脂多糖促巨噬细胞氧化应激损伤作用的研究[J]. 国际口腔医学杂志,2022, 49(5): 521-528.
白琳,杨雨欣,万巧凤,等. 黄芩苷经TLR2/NF-κB途径减轻类风湿关节炎大鼠滑膜炎 [J]. 中国药理学通报,2017, 33(11): 1569-1573.
苏乙花,汪云鑫,陈学武. 安石榴甙对骨肉瘤细胞增殖、迁移和侵袭的影响及其机制研究[J]. 东南大学学报(医学版),2022, 41(2): 170-175.
GE G, BAI J, WANG Q, et al. Punicalagin ameliorates collagen-induced arthritis by downregulating M1 macrophage and pyroptosis via NF-κB signaling pathway[J]. Sci China Life Sci, 2022, 65(3): 588-603.
许奕夫,姚鑫. 高良姜素抑制乳腺癌转移作用机制研究[J]. 中草药,2016, 47(10): 1731-1739.
HUH J E, JUNG I T, CHOI J, et al. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages[J]. Eur J Pharmacol, 2013, 698(1-3): 57-66.
黄建青,陈阳,丘水林,等. 仙茅苷调控miR-1247-3p表达对高糖诱导的肾小管上皮细胞炎症反应的影响[J]. 中国免疫学杂志,2022, 38(24): 2997-3001.
陈儒,王卫国. 基于网络药理学分析仙茅苷治疗骨质疏松症的潜在靶点[J]. 山东中医杂志,2020, 39(8): 861-867.
王文琪. 仙茅苷通过调节线粒体应激缓解阿尔兹海默症症状的研究[D]. 长春:吉林大学,2021.
DING H, GAO G, ZHANG L, et al. The protective effects of curculigoside A on adjuvant-induced arthritis by inhibiting NF-кB/NLRP3 activation in rats[J]. Int Immunopharmacol, 2016, 30: 43-49.
黄莹,吕美娜,刘珈杏,等. 姜黄素衍生物FM0807的急性毒性及改善脓毒症小鼠生存率的影响 [J]. 中国临床药理学杂志,2019, 35(20): 2623-2625, 2635.
罗玉蓉,吴伟芳,许钊溢,等. 姜黄素衍生物——FM0807的镇痛作用研究[J]. 中国临床药理学杂志,2019, 35(13): 1346-1348.
孙各琴,彭祖旺,胡文波,等. 姜黄素衍生物FM0817体外抗多药耐药铜绿假单胞菌作用 [J]. 中华医院感染学杂志,2013, 23(1): 8-10.
叶丽香. 姜黄素衍生物FM0807的合成及其抗肿瘤抗炎活性研究 [D]. 福州:福建医科大学,2010.
ZHANG N, LIU Z, LUO H, et al. FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways[J]. Biosci Rep, 2019, 39(9): BSR20182263.
赵霞,蔡莉,李荣,等. 五乙酰栀子苷对CUMS大鼠抑郁行为及其对HPA轴的影响[J]. 安徽医科大学学报,2017, 52(8): 1164-1168.
李春梅. 五乙酰栀子苷对佐剂性关节炎大鼠的治疗作用及对成纤维样滑膜细胞的促凋亡作用[D]. 合肥:安徽医科大学,2019.
王思明,王溪,苏晓会,等. 续随子中千金二萜烷化合物抑制人妇科肿瘤细胞增殖活性的研究[J]. 中国药理学通报,2011, 27(6): 774-776.
唐静. 大戟因子L2对类风湿关节炎的抗炎作用及其分子机制研究[D]. 泸州:西南医科大学,2020.
TANG J, CHENG X, YI S, et al. Euphorbia factor L2 ameliorates the progression of K/BxN serum-induced arthritis by blocking TLR7 mediated IRAK4/IKKβ/IRF5 and NF‑κB signaling pathways[J]. Front Pharmacol, 2021, 12: 773592.
王春,袁君,魏伟. 芍药苷-6-O'-苯磺酸酯体外降解动力学研究[J]. 安徽医科大学学报,2014, 49(9): 1269-1274.
SHU J L, ZHANG X Z, HAN L, et al. Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF‑κB signaling: comparison with biological agents [J]. Acta Pharmacol Sin, 2019, 40(6): 801-813.
谢运飞,李芸霞,谢红军,等. 附子脂溶性生物碱与白芍总苷配伍治疗风寒湿痹证模型大鼠的增效作用研究[J]. 中国药房,2019, 30(20): 2772-2777.
GUO C, HE L, HU N, et al. Aconiti lateralis radix praeparata lipid-soluble alkaloids alleviates IL-1β-induced inflammation of human fibroblast-like synoviocytes in rheumatoid arthritis by inhibiting NF‑κB and MAPKs signaling pathways and inducing apoptosis[J]. Cytokine, 2022, 151: 155809.
NOORT A R, TAK P P, TAS S W. Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?[J]. Arthritis Res Ther, 2015, 17(1): 15.
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构